(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HYTEST

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

HYTEST

ST13

US500000079314785

Class

1, 5, 35, 42

Filing

79314785

Registration

6861541

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

09/27/2025

Trademark type

Word

Nice classes

1, 5, 35, 42

Filing date

03/22/2021

Registration date

10/04/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/04/2022

Last transaction

09/27/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

FI

Examiner

SEGAL,MOLLY DANIELA

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Hytest Oy

Representatives

Elizabeth A. Cominolli Markert & Cominolli PLLC

Technical classification

Nice Classes

Class 1Class 5Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical preparations for analyses in laboratoriesother than for medical or veterinary purposes; Biological preparations for use in cell culturesother than for medical or veterinary purposes; Diagnostic preparationsother than for medical or veterinary purposes; Biochemicalsnamely monoclonal antibodies for scientific purposesother than for medical or veterinary use; Tagged antibodies for scientific use; Tagged antibodies for laboratory use; Monoclonal antibodies for diagnostic useother than for medical use; Monoclonal antibodies for scientific use; Monoclonal antibodies for industrial use; Monoclonal antibody reagentsother than for medical use; Reagents for scientific purposes; Laboratory reagents for scientific use; Reagents for use in the development of monoclonal antibodiesother than for medical or veterinary purposes

Class 5

Diagnostic preparations for medical purposes; In vitro diagnostic preparations for medical use; Diagnostic preparations for veterinary purposes; Reagents for medical use; Veterinary diagnostic reagents; Diagnostic preparationsantigens for medical use; Antibodies for medical use; Monoclonal antibodies for medical use; Medical preparationspolyclonal antibodies; Blood plasma; serums for use in medical laboratory research in the field of biotechnology and for manufacturing medical preparations; Monoclonal antibodies and antigens used to carry out medical laboratory tests; Antibodiesantigensserums and blood plasma for immunoassay reagent development on various platforms for medical use; Monoclonal antibodies and antigens that enable the development of quantitative immunoassays for the detection of various biomarkers for medical use; Antibodies and antigens that enable the development of immunoassays for the detection of infectious diseases causing pathogens; Antibodies and antigens that allow the development of quantitative immunoassays for detecting inflammatory markers for medical use

Class 35

Retail store services featuring medical preparations; Retail store services featuring veterinary preparations; Retail store services featuring antibodiesantigensblood plasma and serums; Online retail store services featuring medical preparations; Online retail store services featuring veterinary preparations; Online retail store services featuring antibodiesantigensblood plasma and serums; Wholesale store services featuring medical preparations; Wholesale store services featuring veterinary preparations; Wholesale store services featuring antibodiesantigensblood plasma and serums; Online wholesale store services featuring antibodiesantigensblood plasma and serums

Class 42

Research laboratories in the field of biotechnology; Biological research laboratory services; Medical research services; Research and development relating to in vitro diagnostic preparations; Research and development services in the field of antibodies; Research and development services in the field of antigens; Medical laboratory services; Medical laboratory services relating to the production of monoclonal antibodies; Medical laboratory services relating to the production of antigens; Medical laboratory services relating to the production of blood plasma and serums; Testing and authentication for quality control purposes; Biotechnology testingnamely biotechnology research; Testing of pharmaceuticals; Consultancy relating to laboratory testing; Providing scientific information relating to diagnostic in vitro products and their features

Publications

History of USPTO decisions and trademark events.

33 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

09/26/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/20/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/26/2023

FIMP

FINAL DISPOSITION PROCESSED

01/26/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/04/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/04/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

10/04/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/19/2022

PUBO

PUBLISHED FOR OPPOSITION

07/19/2022

GPNX

NOTIFICATION PROCESSED BY IB

07/18/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

06/29/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

06/29/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/29/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/14/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

06/14/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/14/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

06/14/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/14/2022

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

06/14/2022

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

05/24/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/09/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/13/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/13/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/13/2022

RFNT

REFUSAL PROCESSED BY IB

12/26/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/03/2021

RFRR

REFUSAL PROCESSED BY MPU

12/03/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/03/2021

CNRT

NON-FINAL ACTION WRITTEN

11/02/2021

DOCK

ASSIGNED TO EXAMINER

10/26/2021

MAFR

APPLICATION FILING RECEIPT MAILED

07/13/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/08/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/01/2021

Continuous trademark protection

Get notified about every new filing that threatens HYTEST or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.